Shay Shemesh Nuvectis Pharma, Inc. (NVCT) insider trading activity

NVCT Quotes by TradingView

Shay Shemesh is Chief Dev. & Ops. Officer of Nuvectis Pharma, Inc.. Currently has a direct ownership of 1.79 Million shares of NVCT, which is worth approximately $10.8 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.79M
9.13% 3M change
9.13% 12M change
Total Value Held $10.8 Million

Shay Shemesh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
BUY
Grant, award, or other acquisition
-
150,000 Added 7.72%
1,793,068 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
150,000 Added 8.37%
1,643,068 Common Stock
May 10 2024
BUY
Open market or private purchase
$7,034 $6.32 p/Share
1,113 Added 0.07%
1,493,068 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
130,000 Added 8.02%
1,491,955 Common Stock
Mar 21 2023
BUY
Open market or private purchase
$5,035 $11.99 p/Share
420 Added 0.03%
1,361,955 Common Stock
Mar 15 2023
BUY
Open market or private purchase
$7,175 $10.71 p/Share
670 Added 0.05%
1,361,535 Common Stock
Jan 12 2023
BUY
Grant, award, or other acquisition
-
115,000 Added 7.79%
1,360,865 Common Stock
Dec 21 2022
BUY
Open market or private purchase
$3,825 $7.65 p/Share
500 Added 0.04%
1,245,865 Common Stock
Nov 17 2022
BUY
Open market or private purchase
$1,080 $7.2 p/Share
150 Added 0.01%
1,245,365 Common Stock
Nov 16 2022
BUY
Open market or private purchase
$1,065 $7.1 p/Share
150 Added 0.01%
1,245,215 Common Stock
Sep 23 2022
BUY
Open market or private purchase
$1,731 $7.87 p/Share
220 Added 0.02%
1,245,065 Common Stock
Sep 02 2022
BUY
Open market or private purchase
$3,357 $8.31 p/Share
404 Added 0.03%
1,244,845 Common Stock
Sep 01 2022
BUY
Open market or private purchase
$12,347 $8.07 p/Share
1,530 Added 0.12%
1,244,441 Common Stock
Aug 31 2022
BUY
Open market or private purchase
$11,911 $8.07 p/Share
1,476 Added 0.12%
1,242,911 Common Stock
May 20 2022
BUY
Open market or private purchase
$4,962 $16.54 p/Share
300 Added 0.02%
1,241,435 Common Stock
May 17 2022
BUY
Open market or private purchase
$2,776 $19.55 p/Share
142 Added 0.01%
1,241,135 Common Stock
May 16 2022
BUY
Open market or private purchase
$1,928 $19.28 p/Share
100 Added 0.01%
1,240,993 Common Stock
May 12 2022
BUY
Open market or private purchase
$20,039 $15.68 p/Share
1,278 Added 0.1%
1,240,893 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
60,000 Added 4.62%
1,239,615 Common Stock
Feb 07 2022
BUY
Open market or private purchase
$2,936 $3.47 p/Share
846 Added 0.07%
1,179,615 Common Stock, par valu...
Feb 04 2022
BUY
Open market or private purchase
$7,098 $3.38 p/Share
2,100 Added 0.18%
1,178,769 Common Stock, par valu...
SS

Shay Shemesh

Chief Dev. & Ops. Officer
Fort Lee, NJ

Track Institutional and Insider Activities on NVCT

Follow Nuvectis Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCT shares.

Notify only if

Insider Trading

Get notified when an Nuvectis Pharma, Inc. insider buys or sells NVCT shares.

Notify only if

News

Receive news related to Nuvectis Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVCT